BioScrip (NASDAQ: BIOS) today announced that the Company will release its 2011 fourth quarter and full year financial results before the market opens on Friday, March 9, 2012, and host a conference call at 8:30 a.m. Eastern Standard Time (EST) to discuss the results. Richard M. Smith, President and Chief Executive Officer, and MJ Graves, interim Chief Financial Officer and Treasurer, will conduct the call. Interested parties may participate in the conference call by dialing 800-707-7427 (US), or 303-223-2680 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available for two weeks after the call's completion by dialing 800-633-8284 (US) or 402-977-9140 (International) and entering conference call ID number 21579469. An audio webcast and archive will also be available under the “Investor Relations” section of the BioScrip website at www.bioscrip.com. About BioScrip BioScrip, Inc. (www. bioscrip.com) (Nasdaq: BIOS) is a national provider of pharmacy and home health services that partners with patients, physicians, hospitals, payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications and home health services. Our services are designed to improve clinical outcomes to patients with chronic and acute healthcare conditions while controlling overall healthcare costs.